Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
Simon Francis Thomsen,1,2 Freja Lærke Sand1,2 1Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark; 2Department of Biomedical Sciences, University of Copenhagen, Copenhagen, DenmarkWe read with interest the recent paper by Cooke et al about the use of biologic agents for in...
Guardado en:
Autores principales: | Thomsen SF, S, FL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/191f30cb7bf14125b05761e9cfef3b22 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
por: Sara Salvador-Martín, et al.
Publicado: (2021) -
Use of non-TNF biologics for the treatment of neuro-Behçet’s disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab
por: Yusuf Karabulut
Publicado: (2021) -
Abatacept in difficult-to-treat juvenile idiopathic arthritis
por: Jasmin B Kuemmerle-Deschner, et al.
Publicado: (2009) -
Role of biologics in intractable urticaria
por: Cooke A, et al.
Publicado: (2015) -
A disease that is difficult to diagnose and treat: evaluation of 343 spondylodiscitis cases
por: Safak Kaya, et al.
Publicado: (2021)